Yehuda Reznick's most recent trade in Rewalk Robotics Ltd. was a trade of 7,657 Ordinary Shares, no par value per share done . Disclosure was reported to the exchange on March 25, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Rewalk Robotics Ltd | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2026 | 7,657 | 7,657 (0%) | 0% | 0 | Ordinary Shares, no par value per share | |
| Oramed Pharma Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 30,000 | 98,930 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 6,250 | 105,180 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 30,000 | 60,560 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 8,370 | 68,930 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 760 | 30,560 (0%) | 0% | - | Common Stock | |
| Oramed Pharma Inc | Yehuda Reznick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Apr 2024 | 29,800 | 29,800 (0%) | 0% | - | Common Stock |